Compare Stocks → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSEAMERICAN:ASTCVE:IFRCVE:NZCVE:PNNCVE:VUL Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASTAsterias Biotherapeutics$0.00$0.00$0.51▼$2.05$111KN/A136,653 shs1,000 shsIFRInternational Frontier ResourcesC$0.09+50.0%C$0.07C$0.05▼C$0.20C$1.35M1.3811,249 shs33,875 shsNZNew Zealand EnergyC$1.15C$0.83C$0.30▼C$1.67C$9.57M2.96,458 shs4,600 shsPNNPambili Natural ResourcesC$0.06+10.0%C$0.05C$0.04▼C$0.10C$1.43M-2.2634,542 shs10,638 shsVULVulcan MineralsC$0.16C$0.15C$0.11▼C$0.28C$20.61M2.4675,745 shs101,228 shsThe 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceIFRInternational Frontier Resources0.00%0.00%+38.46%+80.00%+260.00%NZNew Zealand Energy0.00%+9.52%+43.75%+40.24%+1,337.50%PNNPambili Natural Resources+10.00%-21.43%+37.50%0.00%+1,000.00%VULVulcan Minerals0.00%0.00%+6.67%+33.33%-20.00%Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AIFRInternational Frontier ResourcesN/AN/AN/AN/AN/AN/AN/AN/ANZNew Zealand EnergyN/AN/AN/AN/AN/AN/AN/AN/APNNPambili Natural ResourcesN/AN/AN/AN/AN/AN/AN/AN/AVULVulcan MineralsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASTAsterias BiotherapeuticsN/AN/AN/AN/AIFRInternational Frontier ResourcesN/AN/AN/AN/ANZNew Zealand EnergyN/AN/AN/AN/APNNPambili Natural ResourcesN/AN/AN/AN/AVULVulcan MineralsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AN/AIFRInternational Frontier ResourcesN/AN/AC$0.01 per share12.50C($0.09) per shareN/ANZNew Zealand EnergyC$2.60M3.68C$0.38 per share3.00C$0.72 per share1.60PNNPambili Natural ResourcesN/AN/AC$0.02 per share2.50C($0.04) per shareN/AVULVulcan MineralsC$1.25M16.49C$0.03 per share5.27C$0.34 per share0.47Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASTAsterias BiotherapeuticsN/AN/A0.00∞N/AN/AN/AN/AN/AIFRInternational Frontier Resources-C$3.86M-C$0.03N/A∞N/AN/A-501.04%-61.18%6/4/2024 (Estimated)NZNew Zealand EnergyC$1.52MC$0.205.75∞N/A13.51%24.17%0.19%6/4/2024 (Estimated)PNNPambili Natural ResourcesN/A-C$0.03N/A∞N/AN/AN/A-65.58%N/AVULVulcan Minerals-C$2.02MN/AN/A∞N/A2.15%0.02%-0.73%6/4/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASTAsterias BiotherapeuticsN/AN/AN/AN/AN/AIFRInternational Frontier ResourcesN/AN/AN/AN/AN/ANZNew Zealand EnergyN/AN/AN/AN/AN/APNNPambili Natural ResourcesN/AN/AN/AN/AN/AVULVulcan MineralsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASTAsterias BiotherapeuticsN/AN/AN/AIFRInternational Frontier Resources8.430.090.22NZNew Zealand Energy145.520.330.45PNNPambili Natural Resources60.930.020.27VULVulcan Minerals0.0767.22173.87OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASTAsterias BiotherapeuticsN/AIFRInternational Frontier ResourcesN/ANZNew Zealand EnergyN/APNNPambili Natural ResourcesN/AVULVulcan MineralsN/AInsider OwnershipCompanyInsider OwnershipASTAsterias BiotherapeuticsN/AIFRInternational Frontier Resources28.89%NZNew Zealand Energy42.69%PNNPambili Natural Resources13.92%VULVulcan Minerals17.06%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableASTAsterias BiotherapeuticsN/A55.66 millionN/ANot OptionableIFRInternational Frontier Resources614.96 millionN/ANot OptionableNZNew Zealand EnergyN/A8.32 millionN/ANot OptionablePNNPambili Natural ResourcesN/A25.95 millionN/ANot OptionableVULVulcan MineralsN/A128.83 millionN/ANot OptionableAST, NZ, IFR, VUL, and PNN HeadlinesSourceHeadlineThe battle over an asphalt plant in Sahuarita comes to an endmsn.com - April 25 at 3:56 PMPosts by Bloomberg News:mining.com - April 12 at 8:00 PMHotter-than-expected US inflation print rattles boursemsn.com - April 12 at 9:58 AMDenarius Metals Announces Positive Pre-Feasibility Study Results Supporting a Restart of ...goldseiten.de - April 11 at 6:12 PMAI's unusual impact on interest ratesinvestorschronicle.co.uk - April 11 at 6:12 PMVulcan Minerals Inc: Springdale Copper-Gold Project in Newfoundland Continues to Provide Encouraging Exploration Resultsfinanznachrichten.de - March 21 at 6:55 PMVulcan offer falls through, but MC Mining still recommends not accepting Goldway dealminingweekly.com - March 12 at 8:35 AMThe future of uranium mining in Australiamining-technology.com - March 11 at 8:31 AMEuropean Union considers Vulcan debt supportmining-journal.com - February 23 at 5:20 AMFLSmidth to provide pumps for iron ore pellet plant in Omanworldpumps.com - February 15 at 10:16 AMVulcan Minerals Inc. - Red Cross Lake Delivers Stellar Nickel-Copper-Cobalt Soil Anomaly in Newfoundlandfinanznachrichten.de - February 8 at 3:13 PM‘Gotta keep your hands fresh’: why male athletes are wearing nail polishtheguardian.com - January 31 at 8:37 AMClosing Bell: Vulcan Minerals Inc flat on Monday (VUL)theglobeandmail.com - January 30 at 5:26 PMTourist Discovers Massive 7.46-Carat Diamond at Arkansas' Crater of Diamonds State Parkyahoo.com - January 27 at 9:55 PMAstrobotic lander burns up in Earth reentry after missing shot at the moonsun-sentinel.com - January 19 at 1:15 PMWhich former Fortescue executive is joining Vulcan Energy to lead its finance team?msn.com - January 15 at 1:06 AMForrest insider joins Rinehart-backed lithium playafr.com - January 14 at 8:06 PMNative American News Roundup Jan. 7-13, 2024voanews.com - January 13 at 8:04 AMVulcan Minerals: High Grade Copper Intersected at McNeily Zone in Newfoundlandjuniorminingnetwork.com - January 12 at 3:46 PMVulcan Minerals Inc. – High Grade Copper Intersected at McNeily Zone in Newfoundlandfinance.yahoo.com - January 12 at 10:36 AMMoon lander problem threatens mission after Vulcan rocket’s successful debutmsn.com - January 9 at 1:33 PMFirst US moonshot in 50 years appears doomed after lift-offtheage.com.au - January 8 at 8:39 PMLunar lander issue complicates privately-led U.S. moon missioncbc.ca - January 8 at 8:39 PMFirst US moon landing in 50 years appears doomed after lift-offsmh.com.au - January 8 at 8:39 PMMedia Sentiment Over TimeTop HeadlinesFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains ImminentBreakout Alert: Coinbase's Consolidation Is About To EndApril 12, 2024 9:45 AMView Breakout Alert: Coinbase's Consolidation Is About To EndDisney Stock Catches 3 Upgrades In a Single WeekMarch 28, 2024 10:27 AMView Disney Stock Catches 3 Upgrades In a Single WeekBuy the Dip in Netflix Stock, It Won’t Last LongApril 19, 2024 8:32 AMView Buy the Dip in Netflix Stock, It Won’t Last LongDividend Aristocrat Fastenal Goes on Sale: Buy It While It’s DownApril 11, 2024 12:07 PMView Dividend Aristocrat Fastenal Goes on Sale: Buy It While It’s DownAll Headlines Company DescriptionsAsterias BiotherapeuticsNYSEAMERICAN:ASTAsterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.International Frontier ResourcesCVE:IFRInternational Frontier Resources Corporation acquires, develops, exploits, and produces oil and natural gas in Mexico. The company has oil and natural gas interests in the Central Mackenzie Valley, Northwest Territories, Canada; and owns mineral titles covering an area of 15,200 acres located in Northwest Montana. The company has a strategic alliance with SIMMONS EDECO to pursue oil and gas operations in the Mexican market primarily focused on upstream oil and gas, as well as midstream and service contract opportunities. The company was founded in 1995 and is headquartered in Calgary, Canada.New Zealand EnergyCVE:NZNew Zealand Energy Corp., together with its subsidiaries, engages in the exploration and production of oil and natural gas in New Zealand. It holds interests in three petroleum mining licenses, one petroleum mining permit, and one petroleum exploration permit. The company has interests in TWN Petroleum Mining Licenses comprising Waihapa/Ngaere, and Tariki; Copper Moki petroleum mining permit; and Eltham Petroleum exploration permit. It also operates midstream assets. The company was founded in 2010 and is based in New Plymouth, New Zealand.Pambili Natural ResourcesCVE:PNNPambili Natural Resources Corporation engages in the evaluation, acquisition, exploration, and development of oil and gas properties in Canada and Zimbabwe. It operates Happy Valley gold mine in Bulawayo, Zimbabwe. The company was formerly known as Pennine Petroleum Corporation and changed its name to Pambili Natural Resources Corporation in June 2022. Pambili Natural Resources Corporation was incorporated in 2001 and is headquartered in Calgary, Canada.Vulcan MineralsCVE:VULVulcan Minerals Inc., a precious and base metals exploration company, engages in the acquisition, evaluation, and exploration of mineral properties in Newfoundland and Labrador. It primarily explores for copper, gold, nickel, cobalt, salt, and gypsum deposits. The company owns interests in the Colchester/Springdale project located in north-central Newfoundland; and Red Cross Lake nickel/copper/cobalt/gold project in central Newfoundland, as well as mineral licenses covering a portion of the Bay St. George Basin in Western Newfoundland. Vulcan Minerals Inc. was incorporated in 1995 and is headquartered in St. John's, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.